• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

First-Time Generics - August 2009

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 AZELASTINE HYDROCHLORIDE OPHTHALMIC SOLUTION,0.05% APOTEX INC. OPTIVAR OPHTHALMIC SOLUTION 8/3/2009
2 OXALIPLATIN INJECTION,5 MG/ML; (PRESERVATIVE-FREE),PACKAGED IN 50 MG/10 ML AND100 MG/20 MLSINGLE-USE VIALS HOSPIRA WORLDWIDE PTY ELOXATIN INJECTION 8/7/2009
3 OXALIPLATIN FOR INJECTION,(PRESERVATIVE-FREE),PACKAGED IN 50 MG AND100 MG SINGLE-USE VIALS SUN PHARMA GLOBAL, FZE ELOXATIN FOR INJECTION 8/7/2009
4 OXALIPLATIN FOR INJECTION,50 MG AND100 MG(PRESERVATIVE-FREE)SINGLE-USE VIALS FRESENIUS KABI ONCOLOGY, PLC ELOXATIN FOR INJECTION 8/7/2009
5 TACROLIMUS CAPSULES0.5 MG,1 MG AND5 MG SANDOZ, INC. PROGRAF CAPSULES, 0.5 MG, 1 MG AND 5 MG 8/10/2009
6 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE GEL1% (BASE)/5% DOW PHARMACEUTICAL SCIENCES, INC. BENZACLIN TOPICAL GEL 8/11/2009
7 ASPIRIN AND DIPYRIDAMOLE EXTENDED-RELEASE CAPSULES,25 MG/200 MG BARR LABORATORIES, INC. AGGRENOX EXTENDED-RELEASE CAPSULES 8/14/2009
8 CLONIDINE TRANSDERMAL SYSTEM, USP0.1 MG/DAY,0.2 MG/DAY AND0.3 MG/DAY AVEVA DRUG DELIVERY SYSTEMS, INC. CATAPRES-TTS 8/18/2009
9 LEVONORGESTREL TABLETS, (RX/OTC)0.75 MG WATSON LABORATORIES, INC. PLAN B TABLETS 8/28/2009
-
-